SCHEMBL25645754

SCHEMBL25645754

c1ccc(-c2nc(-c3cccc(-c4ccc5c(c4)sc4cccc(-c6ccccc6)c45)c3)nc(-c3ccc4c(c3)oc3ccccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.36
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
PLA2G10 O15496 1/20 0.33
LIMK1 P53667 1/20 0.33
AHR P35869 1/20 0.33
MAPT P10636 4/20 0.32
F9 P00740 1/20 0.32
ALOX5 P09917 1/20 0.32
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 2/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
SLC9A1 P19634 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25851956 0.99 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL25851955 0.98 HCRTR1 (0.36) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL22760673 0.98 HCRTR1 (0.36) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL25646015 0.98 HCRTR1 (0.35) HCRTR1MMP12MMP13LIMK1AHR
SCHEMBL25645850 0.97 HCRTR1 (0.34) HCRTR1MMP12MMP13LIMK1AHR
SCHEMBL25645660 0.96 HCRTR1 (0.36) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL19802203 0.95 MMP12 (0.35) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23913450 0.94 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL25645666 0.94 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL26001991 0.94 HCRTR1 (0.34) HCRTR1PLA2G2APLA2G4AMMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 HCRTR1 337/4885PLA2G2A 3909/4885PLA2G4A 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.